Profile
| Role | EVP, Chief Financial Officer |
|---|---|
| Notability | 20/100 |
Board memberships
- Prestige Consumer Healthcare Inc.
Updated Jul 16, 2026
DArecca James has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
| Role | EVP, Chief Financial Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-19 | HAE | HAEMONETICS CORP | A — Grant or award | 29.3K | — | |
| 2026-05-19 | HAE | HAEMONETICS CORP | F — Tax withholding / forfeiture | 2.5K | $56.29 | $141K |
| 2026-05-05 | HAE | HAEMONETICS CORP | F — Tax withholding / forfeiture | 655 | $59.26 | $39K |
| 2025-08-05 | PBH | Prestige Consumer Healthcare Inc. | A — Grant or award | 2.1K | $0.00 |
DArecca James is a corporate insider — currently tracked as EVP, Chief Financial Officer of HAEMONETICS CORP (HAE). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live DArecca James profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.